RIGL
Price
$20.17
Change
-$0.26 (-1.27%)
Updated
Jul 25 closing price
Capitalization
360.49M
ROQAF
Price
$0.02
Change
-$0.03 (-60.00%)
Updated
Jul 14 closing price
Capitalization
2.99M
Interact to see
Advertisement

RIGL vs ROQAF

Header iconRIGL vs ROQAF Comparison
Open Charts RIGL vs ROQAFBanner chart's image
Rigel Pharmaceuticals
Price$20.17
Change-$0.26 (-1.27%)
Volume$164.02K
Capitalization360.49M
Roquefort Therapeutics
Price$0.02
Change-$0.03 (-60.00%)
Volume$1K
Capitalization2.99M
RIGL vs ROQAF Comparison Chart in %
Loading...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RIGL vs. ROQAF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RIGL is a StrongBuy and ROQAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (RIGL: $20.17 vs. ROQAF: $0.02)
Brand notoriety: RIGL and ROQAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RIGL: 85% vs. ROQAF: 145%
Market capitalization -- RIGL: $360.49M vs. ROQAF: $2.99M
RIGL [@Biotechnology] is valued at $360.49M. ROQAF’s [@Biotechnology] market capitalization is $2.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RIGL’s FA Score shows that 0 FA rating(s) are green whileROQAF’s FA Score has 1 green FA rating(s).

  • RIGL’s FA Score: 0 green, 5 red.
  • ROQAF’s FA Score: 1 green, 4 red.
According to our system of comparison, both RIGL and ROQAF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RIGL’s TA Score shows that 5 TA indicator(s) are bullish while ROQAF’s TA Score has 0 bullish TA indicator(s).

  • RIGL’s TA Score: 5 bullish, 4 bearish.
  • ROQAF’s TA Score: 0 bullish, 4 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than ROQAF.

Price Growth

RIGL (@Biotechnology) experienced а +7.29% price change this week, while ROQAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($360M) has a higher market cap than ROQAF($2.99M). RIGL YTD gains are higher at: 19.917 vs. ROQAF (-57.300).
RIGLROQAFRIGL / ROQAF
Capitalization360M2.99M12,028%
EBITDA48.5MN/A-
Gain YTD19.917-57.300-35%
P/E Ratio9.65N/A-
Revenue203MN/A-
Total Cash77.1MN/A-
Total Debt61.1MN/A-
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RIGLROQAF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
33%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
20%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
71%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROQAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FHRT24.00N/A
N/A
First Hartford Corp.
IPGDF3.60N/A
N/A
IGO Ltd
PPRUF260.00N/A
N/A
Kering SA
ALFNF15.20N/A
N/A
Alfen NV
SMTLF0.04N/A
N/A
GCL New Energy Holdings Ltd.

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-1.27%
CLNN - RIGL
92%
Closely correlated
-0.27%
PHIO - RIGL
84%
Closely correlated
+9.16%
AZTR - RIGL
84%
Closely correlated
-4.34%
IMRN - RIGL
82%
Closely correlated
-1.15%
MNMD - RIGL
43%
Loosely correlated
+0.41%
More

ROQAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROQAF has been closely correlated with LYRA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if ROQAF jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROQAF
1D Price
Change %
ROQAF100%
N/A
LYRA - ROQAF
85%
Closely correlated
-2.33%
EYPT - ROQAF
37%
Loosely correlated
-0.10%
RIGL - ROQAF
22%
Poorly correlated
-1.27%
RYTM - ROQAF
21%
Poorly correlated
-0.94%
OKYO - ROQAF
3%
Poorly correlated
-0.36%
More